Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
주식 순위 #17926
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
주가
$18.20
마지막 동기화: 2025-05-09
시가총액
$220.35M
변동 (1일)
-5.34%
변동 (1년)
0.00%
국가
JP
거래 I'rom Group Co., Ltd. (2372)

카테고리

I'rom Group Co., Ltd. (2372)의 P/B 비율
September 2026 기준 P/B 비율 TTM: 2.64
I'rom Group Co., Ltd.의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 2.64입니다. 2023년 말 기준 P/B 비율은 1.88였습니다.
I'rom Group Co., Ltd.의 P/B 비율 기록 (2005 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
2026 (TTM) 2.64 51.13%
2024 1.75 -7.25%
2023 1.88 -17.84%
2022 2.29 -32.09%
2021 3.38 59.04%
2020 2.12 -27.92%
2019 2.95 -52.22%
2018 6.16 81.16%
2017 3.40 0.32%
2016 3.39 -14.29%
2015 3.96 142.80%
2014 1.63 25.60%
2013 1.30 17.04%
2012 1.11 50.67%
2011 0.74 -10.38%
2010 0.82 -13.31%
2009 0.95 48.53%
2008 0.64 -38.17%
2007 1.03 -74.98%
2006 4.12 -70.24%
2005 13.85 0.00%
유사 기업 또는 경쟁사의 P/B 비율